Tag: Trastuzumab deruxtecan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Trastuzumab deruxtecan

Priority Review Granted for Trastuzumab Deruxtecan; Would Be First Tumor-Agnostic ADC

Added to Collection on: 2024-01-30 19:57:09

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugates
Daiichi Sankyo
Trastuzumab deruxtecan
Immunology
Trastuzumab
HER2
Pertuzumab
Targeted therapy
Breast cancer
Cancer biomarker
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca Pharma gets CDSCO nod for Trastuzumab deruxtecan use for 2 more indications

Added to Collection on: 2024-03-29 16:17:37

Tags for this article:

Antibody-drug conjugates
Orphan drugs
Cancer treatments
Daiichi Sankyo
Trastuzumab deruxtecan
Immunology
Trastuzumab
HER2
Breast cancer
Drugs Controller General of India
Trastuzumab emtansine
Pertuzumab
ASTRAZENECA PHARMA INDIA

Click the tags to see associated articles and topics

View Article Details
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

Added to Collection on: 2024-04-12 14:57:58

Tags for this article:

Orphan drugs
Antibody-drug conjugates
Cancer treatments
Daiichi Sankyo
Trastuzumab deruxtecan
HER2
Non-small-cell lung cancer
Pertuzumab

Click the tags to see associated articles and topics

View Article Details
This pharma stock gets the Budget tonic - TradingView

Added to Collection on: 2024-07-23 16:19:38

Tags for this article:

Orphan drugs
Antibody-drug conjugates
Immunology
Antineoplastic drugs
AstraZeneca
Medical research
Durvalumab
Trastuzumab deruxtecan
Trastuzumab
Deruxtecan
Osimertinib
Breast cancer

Click the tags to see associated articles and topics

View Article Details
ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic ...

Added to Collection on: 2024-09-13 19:12:05

Tags for this article:

Breast cancer
Immunology
Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Trastuzumab deruxtecan
Antibody-drug conjugate
HER2
Nancy Lin
Brain metastasis
Trastuzumab
Metastatic breast cancer
Daiichi Sankyo Co Ltd

Click the tags to see associated articles and topics

View Article Details
AZN: ENHERTU Phase IIIb/IV Trial Shows Significant Results In HER2-Positive Breast ... - RTTNews

Added to Collection on: 2024-09-13 17:58:25

Tags for this article:

Breast cancer
Antibody-drug conjugates
Antineoplastic drugs
Immunology
Orphan drugs
Antibody-drug conjugate
Daiichi Sankyo
Trastuzumab deruxtecan
AstraZeneca
Brain metastasis
Metastatic breast cancer
HER2
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
Daiichi, Astra's Enhertu shows clinical activity in brain metastases - Morningstar

Added to Collection on: 2024-09-13 16:29:09

Tags for this article:

Immunology
Breast cancer
Antineoplastic drugs
Antibody-drug conjugates
Orphan drugs
Trastuzumab deruxtecan
Nancy Lin
Antibody-drug conjugate
AstraZeneca
Daiichi Sankyo
HER2
Trastuzumab
AstraZeneca plc
Daiichi Sankyo Co Ltd

Click the tags to see associated articles and topics

View Article Details
AstraZeneca says ENHERTU achieved 61.6% progression-free survival rate in study

Added to Collection on: 2024-09-13 14:11:35

Tags for this article:

Antineoplastic drugs
AstraZeneca
Medical research
Södertälje Municipality
Brain metastasis
Antibody-drug conjugate
Progression-free survival
Trastuzumab deruxtecan
Metastatic breast cancer
Daiichi Sankyo
Oxford–AstraZeneca COVID-19 vaccine

Click the tags to see associated articles and topics

View Article Details
Trastuzumab Deruxtecan Shows Promise in HER2+ BC with Brain Metastases

Added to Collection on: 2024-09-15 18:39:34

Tags for this article:

Orphan drugs
Cancer treatments
Antineoplastic drugs
Breast cancer
Antibody-drug conjugates
Tucatinib
Nancy Lin
Brain metastasis
Trastuzumab deruxtecan
Trastuzumab
HER2
Metastatic breast cancer
Cristina Saura Manich
Capecitabine

Click the tags to see associated articles and topics

View Article Details
Pharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More - October 4, 2024

Added to Collection on: 2024-10-05 06:31:20

Tags for this article:

Antineoplastic drugs
Orphan drugs
Antibody-drug conjugates
Immunology
Cancer treatments
Trastuzumab deruxtecan
Sanofi
Regeneron Pharmaceuticals
Antibody-drug conjugate
Priority review
HER2
Dupilumab

Click the tags to see associated articles and topics

View Article Details